Is Rite Aid a Screaming Buy After Reporting Sales Figures?

Source: Wikimedia Commons

After reporting sales for the month of February, Rite Aid (NYSE: RAD  ) , the world's third-largest publicly traded drugstore chain, saw its shares fall more than 1%. Although the company's performance for the month wasn't bad, it wasn't strong enough to make investors feel motivated to push shares higher. Given this investor reaction, is it safe to say that Rite Aid's upside is limited from here on out, or is now an opportune moment to jump into the fray?

Sales were reasonable but far from great!
For the month, Rite Aid reported that its comparable-store sales rose 1.5%. In its release, the company announced that the growth driver was its pharmacy segment, which saw comparable-store sales rise 3.1% compared to the year-ago period. This was, however, negatively affected by a 1.8% decline in comparable-store sales for the company's front-end operations, as sales relating to flu products dropped by 0.5%.

On a non-comparable basis, Rite Aid reported that sales for the five-week period rose more than 2% from $2.46 billion to $2.52 billion. This improvement came in spite of 36 locations being closed over the past year, which brought the company's store count to 4,587.

But how does Rite Aid stack up to Walgreen?
Now that Rite Aid reported February sales, we can understand how the company stacks up to larger rival Walgreen  (NASDAQ: WBA  ) . Walgreen's February comparable-store sales rose an impressive 4.5%. Unfortunately, investors weren't terribly happy with management's news and sent shares down 2.5% on the following day.

For the month as a whole, Walgreen's revenue rose 5% from approximately $5.8 billion to about $6 billion. Just as in the case of Rite Aid, Walgreen saw an increase in its pharmacy operations, but the company also had good news coming from its front-end operations. Whereas Rite Aid reported a decline in front-end comparable-store sales, Walgreen reported an increase of 2%.

Source: Rite Aid and Walgreen

Looking at the most recent quarter for each company, we see a similar trend. During its quarter, Rite Aid saw sales rise 2.2% from $6.4 billion to $6.6 billion, driven primarily by a 2.1% increase in comparable-store sales. Walgreen performed even better during this period, with revenue rising 5.2% from $18.7 billion to $19.6 billion. This, too, came about because of a 4.5% rise in the company's comparable-store sales.

Source: Rite Aid and Walgreen

Foolish takeaway
Based on the data provided by Rite Aid, it's safe to say that the company experienced a reasonable quarter but nothing that it should boast about. Yes, revenue is rising. But when you see a larger rival like Walgreen posting stronger growth, it's difficult to say smaller, underperforming rival Rite Aid is a strong prospect.

There is one caveat here that investors should consider, though. Over the past few years, Rite Aid has been struggling with significant losses. Between its 2010 and 2012 fiscal years, the company reported an aggregate net loss of $1.4 billion. In an effort to rectify the situation, management embarked on an ambitious plan to focus not so much on growth but instead on improving its cost structure.

As a result of its hard work, the company finally churned a profit of $118.1 million last year and looks to be on track to continue this trend. Whether the company can continue to improve its margins has yet to be seen, but eventually investors will want to see it maintain profitability while growing. Otherwise, improved economies of scale developed over time by competitors like Walgreen and CVS Caremark will pressure the business back into negative territory...and possibly bankruptcy.

Can Rite Aid surge during 2014?
Despite all of its troubles, Rite Aid's recent past suggests that the company could continue to soar. Given this possibility, is the stock the best to own during 2014, or is there a better opportunity for the Foolish investor?

There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2873407, ~/Articles/ArticleHandler.aspx, 9/2/2015 6:47:17 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Daniel Jones

Dan is a Select Freelance writer for The Motley Fool. He focuses primarily on the Consumer Goods sector but also likes to dive in on interesting topics involving energy, industrials, and macroeconomics!

Today's Market

updated 9 hours ago Sponsored by:
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASD 4,636.11 -140.40 -2.94%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/1/2015 4:00 PM
RAD $8.00 Down -0.25 -3.03%
Rite Aid Corp CAPS Rating: ***
WBA $86.04 Down -0.51 -0.59%
Walgreen Boots All… CAPS Rating: ****